The domestic veterinary drug market, which began in late 2012 as a sign of the beginning of the chicken, has been in its fifth year in 2016. This kind of reorganization started from the veterinary drug company, and then began to spread to the veterinary drug distribution, use, research and development. The new regulations and penalties that came to the fore were, indeed, a lot of "pampered" veterinary drugs, and suddenly a little nervous, confused, and inadaptable.
However, it is important to note that the adaptation of the veterinary drug companies is still very strong. The ability to be born with policies and countermeasures has made the vast majority of enterprises start to adapt and get used to the new regulation and situation gradually. Especially after entering 2016, with the improvement of the domestic veterinary drug market, most of the enterprise benefits began to recover in 2016.
As the saying goes, "the scar has forgotten the pain!" This year, veterinary drug companies' drilling, illegal and illegal momentum also began to "recover"!
This can be seen from the national veterinary drug monitoring institute, and the quality supervision of every veterinary drug quality supervision in all parts of the country! You can see two things that are not normal.
The first is the state-level sampling inspection, which can find more large-scale enterprise problems. Current veterinary drug regulation, as long as the national veterinary drug monitoring can detect the small size of the enterprise's violation, the illegal question, this is abnormal. This might suggest that the country's well-intentioned "free veterinary drugs" may be used by some companies as an illegal "golden bell iron cloth".
The second is the larger scale of veterinary drug companies, and began to be listed in the national notification list. Used to be the national unqualified large-scale enterprises, over the years the country's strict regulation and high pressure, disappeared two years later, in this year's national veterinary drug quality supervision and sampling inspection report, the list again! Also, this is still after the sampling inspection, the factory confirmed the sampling procedure!
In addition, domestic veterinary drug market in recent years, there is also a restriction enterprise innovation development abnormal. That is, the veterinary drug manufacturers, competing in the same stage, competing prices, vicious competition. This kind of situation, while in other industries, the veterinary drug market, 2012 years ago is common, however, then the manufacturer will not no bottom line, making the industry usually the profit level of profit and loss line.
This industry's morbid, severe contusion and suppression of the veterinary drug enterprise innovation enthusiasm, in addition to the introduction of external capital injection and the national policy support, this abnormal state enterprise innovation and the technical ability to reinvest woefully inadequate.
From the perspective of classical economics, the price of veterinary drugs should be a reflection of its value. However, nowadays, whether it is bidding for foreign-funded enterprises or raising tender in domestic enterprises, the price is the key to winning the bid, and the technology is taking a back seat. It can only be said that there is a technology that is more likely to attract users' interest, but it is not a bargaining chip. This is not a normal, ecological and sustainable development environment for the industry, and it is expected to continue in 2017.
Looking ahead to 2017, of course, in the face of new problems and irregularities in the veterinary drug market rebound phenomenon, that the country has some new ideas and measures, otherwise, will not put those self-styled 30, 50, regard herself as the leading industry, leading large-scale unqualified industry, a national report!
The briefing is only a clarion call, and the new veterinary drug enterprise flight inspection regime is about to become a reality. Do not see, the flight inspection of human medicine, these years often revoke some enterprise "GMP card"? Furthermore, the power of qr codes will appear in 2017. Today's veterinary drug quality spot check, basically need to find the enterprise to confirm, many enterprises deny! However, companies that enter 2017 and want to deny it again could be "desperate"! Because, after a certain node in 2017, from the country to the place, the veterinary drug products of every manufacturer will not be able to perform this procedure again, the law: province! This will inevitably lead to more so-called "big enterprises" entering the national veterinary drug quality sampling inspection list, and even the enterprises that have been monitored may increase.
Illegal and irregular and drilling loopholes such as honesty, specification development, eventually won't be in the long run, may capsize "meaning" from now on by "discipline" in another, no freedom, limited space, spend the rest of their lives. Therefore, veterinary drug market in 2017, are expected to be a prompted the standardized and orderly, the veterinary drug companies to deeper and higher level development of innovation, only in this way, Chinese veterinary medicine enterprises can grow up to be in the future can effectively participate in international competition.
The veterinary medicine industry will be better in 2017!